Pioneering a skin cell therapy platform to create novel treatments for rare disease, substance abuse disorder, and more.
Embedded Files
Platform
Platform
Using a small sample of a patient's own skin cells, we engineer persistent, controllable expression of therapeutic proteins.
Cell-spray technology enables simple, durable engraftment - no surgery required.
Gene therapy for rare skin diseases
Gene therapy for rare skin diseases
Our transfection technology allows for persistent expression of very large cargoes
Enzyme replacement therapy
Enzyme replacement therapy
Skin grafts function as a scalable metabolic sink for substrate processing
Substance abuse disorders
Substance abuse disorders
Secretion of proteins to digest abused substances or peptides that modify reward pathways: durable solutions
Nick Bayhi, PhD
Chief Executive Officer
VC, Startup, and Pharma experience
Ryan Meyers, MBA
Chairman, Co-founder
VC, PE, management consulting experience
Xiaoyang Wu, PhD
Co-founder, Inventor
Associate Professor
Tissue engineering and regenerative medicine
Ming Wu, PhD
Professor, neurobiology and substance abuse disorder expert
Page updated
Report abuse